Lepthien patent opposition analysis

The comprehensive analysis of Lepthien opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Lepthien

Patent NumberTitleApplicantOpposition DateOpposition Company
- Jun 3, 2026GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD.Apr 8, 2026GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALS, INC.Dec 19, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTIS AGMay 21, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Manufacture Of DegarelixFERRING B.V.Apr 10, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTIS AGJan 17, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis PatientsNOVARTIS AGJan 10, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICAL INC.Dec 13, 2024GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Charged Depth Filtration Of Antigen-Binding ProteinsAMGEN INC.Jun 27, 2024GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Methods For Providing Single-Stranded RnaBIONTECH SEJul 27, 2022LDS LAZEWSKI DEPO & PARTNERS